Matches in SemOpenAlex for { <https://semopenalex.org/work/W3182772422> ?p ?o ?g. }
- W3182772422 endingPage "1158" @default.
- W3182772422 startingPage "1158" @default.
- W3182772422 abstract "<h3>Importance</h3> Black women in the US with endometrial cancer (EC) are more likely to be diagnosed with advanced-stage disease independent of insured status and histologic type. The most common way of diagnosing EC at early stages is through screening of people with postmenopausal bleeding to detect endometrial thickness (ET). This approach may disproportionately underperform in Black women secondary to a higher prevalence of fibroids and nonendometrioid EC in this population, both of which affect the quality of ET measurement. <h3>Objective</h3> To compare the performance of recommended transvaginal ultrasonography (TVUS) ET thresholds as a screening method to prompt endometrial biopsy by race in a simulated cohort of symptomatic women. <h3>Design, Setting, and Participants</h3> In a simulated retrospective cohort study, based on data from Surveillance, Epidemiology, and End Results (SEER) national cancer registry 2012-2016; the US census; and published estimates of ET distribution and fibroid prevalence, diagnostic test characteristics of the 3-mm or more, 4-mm or more, and 5-mm or more ET thresholds for biopsy to capture EC diagnoses were calculated. The simulated cohort was constructed from February 2, 2020 (date of access to SEER data), to August 31, 2020. Analysis occurred from September 30, 2020, to March 30, 2021, including the primary analysis and the sensitivity calculations. <h3>Main Outcomes and Measures</h3> The main outcome measured was accuracy of the TVUS ET threshold to accurately identify cases of EC, measured by sensitivity, negative predictive value, and area under the curve (AUC). <h3>Results</h3> A total of 367 073 simulated Black and White women with postmenopausal bleeding were evaluated, including 36 708 with EC. Among Black women, the currently recommended 4-mm or greater ET threshold prompted biopsy for fewer than half of EC cases (sensitivity, 47.5%; 95% CI, 46.0%-49.0%); of women referred for biopsy, 13.1% were EC cases (positive predictive value, 13.1%; 95% CI, 12.5%-13.6%). The AUC for the 4-mm or more threshold was 0.57 (95% CI, 0.56-0.57). In contrast, among the White women, the 4-mm or more threshold led to biopsy for most with EC (sensitivity, 87.9%; 95% CI, 87.6%-88.3%). Of those referred for biopsy, 14.6% had EC (positive predictive value, 14.6%; 95% CI, 14.4%-14.7%); AUC was 0.73 (95% CI, 0.73-0.74). The same variations held for the 3-mm or more and 5-mm or more ET thresholds: sensitivity, positive predictive value, and AUC were consistently lower for Black women than White women. <h3>Conclusions and Relevance</h3> The findings of this simulated cohort study suggest that use of ET as measured by TVUS to determine the need for EC diagnostic testing in symptomatic women may exacerbate racial disparities in EC stage at diagnosis. In simulated data, TVUS ET screening missed almost 5 times more cases of EC among Black women vs White women owing to the greater prevalence of fibroids and nonendometrioid histologic type in Black women." @default.
- W3182772422 created "2021-07-19" @default.
- W3182772422 creator A5023340631 @default.
- W3182772422 creator A5077802482 @default.
- W3182772422 creator A5078610385 @default.
- W3182772422 creator A5078797234 @default.
- W3182772422 date "2021-08-01" @default.
- W3182772422 modified "2023-10-17" @default.
- W3182772422 title "Estimated Performance of Transvaginal Ultrasonography for Evaluation of Postmenopausal Bleeding in a Simulated Cohort of Black and White Women in the US" @default.
- W3182772422 cites W1551388977 @default.
- W3182772422 cites W1895927552 @default.
- W3182772422 cites W1969018878 @default.
- W3182772422 cites W1982653623 @default.
- W3182772422 cites W1989045983 @default.
- W3182772422 cites W1998630723 @default.
- W3182772422 cites W2017655433 @default.
- W3182772422 cites W2020282949 @default.
- W3182772422 cites W2043242099 @default.
- W3182772422 cites W2049253756 @default.
- W3182772422 cites W2062680563 @default.
- W3182772422 cites W2065172153 @default.
- W3182772422 cites W2068313941 @default.
- W3182772422 cites W2137678331 @default.
- W3182772422 cites W2146511779 @default.
- W3182772422 cites W2155126559 @default.
- W3182772422 cites W2209765995 @default.
- W3182772422 cites W2290355205 @default.
- W3182772422 cites W2313556323 @default.
- W3182772422 cites W2325353837 @default.
- W3182772422 cites W2604748569 @default.
- W3182772422 cites W2760218208 @default.
- W3182772422 cites W2885550086 @default.
- W3182772422 cites W2895607338 @default.
- W3182772422 cites W2945254664 @default.
- W3182772422 cites W3003776107 @default.
- W3182772422 cites W3014455440 @default.
- W3182772422 cites W3087859826 @default.
- W3182772422 cites W4206388699 @default.
- W3182772422 cites W4232516297 @default.
- W3182772422 cites W4251665430 @default.
- W3182772422 cites W4255983923 @default.
- W3182772422 doi "https://doi.org/10.1001/jamaoncol.2021.1700" @default.
- W3182772422 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8283671" @default.
- W3182772422 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34264304" @default.
- W3182772422 hasPublicationYear "2021" @default.
- W3182772422 type Work @default.
- W3182772422 sameAs 3182772422 @default.
- W3182772422 citedByCount "19" @default.
- W3182772422 countsByYear W31827724222021 @default.
- W3182772422 countsByYear W31827724222022 @default.
- W3182772422 countsByYear W31827724222023 @default.
- W3182772422 crossrefType "journal-article" @default.
- W3182772422 hasAuthorship W3182772422A5023340631 @default.
- W3182772422 hasAuthorship W3182772422A5077802482 @default.
- W3182772422 hasAuthorship W3182772422A5078610385 @default.
- W3182772422 hasAuthorship W3182772422A5078797234 @default.
- W3182772422 hasBestOaLocation W31827724222 @default.
- W3182772422 hasConcept C107130276 @default.
- W3182772422 hasConcept C121608353 @default.
- W3182772422 hasConcept C126322002 @default.
- W3182772422 hasConcept C131872663 @default.
- W3182772422 hasConcept C167135981 @default.
- W3182772422 hasConcept C201903717 @default.
- W3182772422 hasConcept C2775934546 @default.
- W3182772422 hasConcept C2776606343 @default.
- W3182772422 hasConcept C2777088508 @default.
- W3182772422 hasConcept C2908647359 @default.
- W3182772422 hasConcept C29456083 @default.
- W3182772422 hasConcept C71924100 @default.
- W3182772422 hasConcept C72563966 @default.
- W3182772422 hasConcept C99454951 @default.
- W3182772422 hasConceptScore W3182772422C107130276 @default.
- W3182772422 hasConceptScore W3182772422C121608353 @default.
- W3182772422 hasConceptScore W3182772422C126322002 @default.
- W3182772422 hasConceptScore W3182772422C131872663 @default.
- W3182772422 hasConceptScore W3182772422C167135981 @default.
- W3182772422 hasConceptScore W3182772422C201903717 @default.
- W3182772422 hasConceptScore W3182772422C2775934546 @default.
- W3182772422 hasConceptScore W3182772422C2776606343 @default.
- W3182772422 hasConceptScore W3182772422C2777088508 @default.
- W3182772422 hasConceptScore W3182772422C2908647359 @default.
- W3182772422 hasConceptScore W3182772422C29456083 @default.
- W3182772422 hasConceptScore W3182772422C71924100 @default.
- W3182772422 hasConceptScore W3182772422C72563966 @default.
- W3182772422 hasConceptScore W3182772422C99454951 @default.
- W3182772422 hasIssue "8" @default.
- W3182772422 hasLocation W31827724221 @default.
- W3182772422 hasLocation W31827724222 @default.
- W3182772422 hasLocation W31827724223 @default.
- W3182772422 hasOpenAccess W3182772422 @default.
- W3182772422 hasPrimaryLocation W31827724221 @default.
- W3182772422 hasRelatedWork W2018760279 @default.
- W3182772422 hasRelatedWork W2033485969 @default.
- W3182772422 hasRelatedWork W2102238462 @default.
- W3182772422 hasRelatedWork W2168082416 @default.
- W3182772422 hasRelatedWork W2326589321 @default.
- W3182772422 hasRelatedWork W2944396186 @default.
- W3182772422 hasRelatedWork W3028296939 @default.